7.04 USD
▼+0.71-2.63%
盘后 7.20 -0.41%
2026-08-03
市值
$9.12M
市盈率
—
EPS
-145.02
股息率
—
52 周区间
3.31 – 1,050.36
成交量
29.59K
Beta
0.11
目标价
—
52W 低 3.3152W 高 1,050.36
价格走势
公司简介
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing form...